Immediate Impact
5 by Nobel laureates 12 from Science/Nature 58 standout
Citing Papers
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
2025 Standout
mRNA-based therapeutics: looking beyond COVID-19 vaccines
2024 StandoutNobel
Works of T. Scott Manetz being referenced
Biodistribution and Toxicological Safety of Adenovirus Type 5 and Type 35 Vectored Vaccines Against Human Immunodeficiency Virus-1 (HIV-1), Ebola, or Marburg Are Similar Despite Differing Adenovirus Serotype Vector, Manufacturer's Construct, or Gene Inserts
2008
Biodistribution of DNA Plasmid Vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile Virus Is Similar, without Integration, despite Differing Plasmid Backbones or Gene Inserts
2006
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| T. Scott Manetz | 475 | 87 | 27 | 280 | 136 | 15 | 811 | |
| Debra D. Hiraki | 573 | 59 | 8 | 130 | 105 | 12 | 897 | |
| Marie-Claude Letellier | 310 | 61 | 5 | 490 | 87 | 17 | 931 | |
| Georgetta Cannon | 311 | 66 | 4 | 317 | 52 | 20 | 709 | |
| E. Wolff‐Schreiner | 448 | 12 | 4 | 169 | 74 | 12 | 851 | |
| Brigid M. Balfour | 612 | 27 | 22 | 141 | 43 | 26 | 859 | |
| Gisela Wohlleben | 408 | 68 | 55 | 169 | 271 | 32 | 889 | |
| A B Reske-Kunz | 468 | 38 | 4 | 112 | 65 | 21 | 694 | |
| Michael P. Gallagher | 548 | 56 | 3 | 327 | 65 | 16 | 863 | |
| J P Kusnierz | 353 | 23 | 18 | 162 | 225 | 23 | 817 | |
| Masazumi Terashima | 214 | 38 | 3 | 307 | 80 | 22 | 660 |
All Works
Loading papers...